6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)

C195H209BBrN19O16P4Pd — CID 157189830

IUPAC6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)
SMILESBrc1ccc2nc(C3CCCC3)[nH]c2c1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc(C6CCCC6)[nH]c5c4)cc3)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)cc3)cc2[nH]1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C42H50N8O6.C34H37N5O2.C28H36BN3O4.4C18H15P.C12H13BrN2.C7H13NO4.Pd/c1-23(2)35(47-41(53)55-5)39(51)49-19-7-9-33(49)37-43-29-17-15-27(21-31(29)45-37)25-11-13-26(14-12-25)28-16-18-30-32(22-28)46-38(44-30)34-10-8-20-50(34)40(52)36(24(3)4)48-42(54)56-6;1-34(2,3)41-33(40)39-18-6-9-30(39)32-36-27-17-15-25(20-29(27)38-32)22-12-10-21(11-13-22)24-14-16-26-28(19-24)37-31(35-26)23-7-4-5-8-23;1-26(2,3)34-25(33)32-16-8-9-23(32)24-30-21-15-12-19(17-22(21)31-24)18-10-13-20(14-11-18)29-35-27(4,5)28(6,7)36-29;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;13-9-5-6-10-11(7-9)15-12(14-10)8-3-1-2-4-8;1-4(2)5(6(9)10)8-7(11)12-3;/h11-18,21-24,33-36H,7-10,19-20H2,1-6H3,(H,43,45)(H,44,46)(H,47,53)(H,48,54);10-17,19-20,23,30H,4-9,18H2,1-3H3,(H,35,37)(H,36,38);10-15,17,23H,8-9,16H2,1-7H3,(H,30,31);4*1-15H;5-8H,1-4H2,(H,14,15);4-5H,1-3H3,(H,8,11)(H,9,10);/t33-,34-,35-,36-;30-;23-;;;;;;5-;/m000.....0./s1
InChIKeyAPOMNUTZFUICIX-BHNYIASISA-N
MW3395.97 g/mol
LogP39.18
Rot. Bonds33

About 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)

6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) (PubChem CID 157189830) has the molecular formula C195H209BBrN19O16P4Pd and a molecular weight of 3395.97 g/mol. Its IUPAC name is 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane).

Molecular Properties

Compound Name6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)
PubChem CID157189830
Molecular FormulaC195H209BBrN19O16P4Pd
Molecular Weight3395.97 g/mol
Exact Mass3392.34
IUPAC Name6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)
SMILESBrc1ccc2nc(C3CCCC3)[nH]c2c1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc(C6CCCC6)[nH]c5c4)cc3)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)cc3)cc2[nH]1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C42H50N8O6.C34H37N5O2.C28H36BN3O4.4C18H15P.C12H13BrN2.C7H13NO4.Pd/c1-23(2)35(47-41(53)55-5)39(51)49-19-7-9-33(49)37-43-29-17-15-27(21-31(29)45-37)25-11-13-26(14-12-25)28-16-18-30-32(22-28)46-38(44-30)34-10-8-20-50(34)40(52)36(24(3)4)48-42(54)56-6;1-34(2,3)41-33(40)39-18-6-9-30(39)32-36-27-17-15-25(20-29(27)38-32)22-12-10-21(11-13-22)24-14-16-26-28(19-24)37-31(35-26)23-7-4-5-8-23;1-26(2,3)34-25(33)32-16-8-9-23(32)24-30-21-15-12-19(17-22(21)31-24)18-10-13-20(14-11-18)29-35-27(4,5)28(6,7)36-29;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;13-9-5-6-10-11(7-9)15-12(14-10)8-3-1-2-4-8;1-4(2)5(6(9)10)8-7(11)12-3;/h11-18,21-24,33-36H,7-10,19-20H2,1-6H3,(H,43,45)(H,44,46)(H,47,53)(H,48,54);10-17,19-20,23,30H,4-9,18H2,1-3H3,(H,35,37)(H,36,38);10-15,17,23H,8-9,16H2,1-7H3,(H,30,31);4*1-15H;5-8H,1-4H2,(H,14,15);4-5H,1-3H3,(H,8,11)(H,9,10);/t33-,34-,35-,36-;30-;23-;;;;;;5-;/m000.....0./s1
InChIKeyAPOMNUTZFUICIX-BHNYIASISA-N
XLogP39.18
TPSA442.53 Ų
H-Bond Donors10
H-Bond Acceptors21
Rotatable Bonds33
Heavy Atoms237
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003395.97
LogP ≤ 539.18
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)?
The IUPAC name of 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) (CID 157189830) is 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane).
What is the SMILES notation for 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)?
The canonical SMILES for 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) is Brc1ccc2nc(C3CCCC3)[nH]c2c1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc(C6CCCC6)[nH]c5c4)cc3)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)cc3)cc2[nH]1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)?
The InChIKey is APOMNUTZFUICIX-BHNYIASISA-N. The full InChI is InChI=1S/C42H50N8O6.C34H37N5O2.C28H36BN3O4.4C18H15P.C12H13BrN2.C7H13NO4.Pd/c1-23(2)35(47-41(53)55-5)39(51)49-19-7-9-33(49)37-43-29-17-15-27(21-31(29)45-37)25-11-13-26(14-12-25)28-16-18-30-32(22-28)46-38(44-30)34-10-8-20-50(34)40(52)36(24(3)4)48-42(54)56-6;1-34(2,3)41-33(40)39-18-6-9-30(39)32-36-27-17-15-25(20-29(27)38-32)22-12-10-21(11-13-22)24-14-16-26-28(19-24)37-31(35-26)23-7-4-5-8-23;1-26(2,3)34-25(33)32-16-8-9-23(32)24-30-21-15-12-19(17-22(21)31-24)18-10-13-20(14-11-18)29-35-27(4,5)28(6,7)36-29;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;13-9-5-6-10-11(7-9)15-12(14-10)8-3-1-2-4-8;1-4(2)5(6(9)10)8-7(11)12-3;/h11-18,21-24,33-36H,7-10,19-20H2,1-6H3,(H,43,45)(H,44,46)(H,47,53)(H,48,54);10-17,19-20,23,30H,4-9,18H2,1-3H3,(H,35,37)(H,36,38);10-15,17,23H,8-9,16H2,1-7H3,(H,30,31);4*1-15H;5-8H,1-4H2,(H,14,15);4-5H,1-3H3,(H,8,11)(H,9,10);/t33-,34-,35-,36-;30-;23-;;;;;;5-;/m000.....0./s1.
What are the key properties of 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane)?
6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) has a molecular weight of 3395.97 g/mol, XLogP of 39.18, 33 rotatable bonds, 10 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-2-cyclopentyl-1H-benzimidazole;tert-butyl (2S)-2-[6-[4-(2-cyclopentyl-3H-benzimidazol-5-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;palladium;tetrakis(triphenylphosphane) is sourced from PubChem (CID 157189830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).